Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC and Vitamin D in HIE Infants
NCT04643821Phase 1Completed
- Sponsor
- Medical University of South Carolina
- Start
- Jan 2015
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label trial of acetylcysteine and calcitriol in hypoxic-ischemic encephalopathy (HIE) (3 arms), sponsored by Medical University of South Carolina. Primary endpoints: Change in pharmacokinetic half life of NAC at 1 week, pharmacokinetic half life of calcitriol at 1 week and 1 more. Started Jan 2015; status: completed.
02
Drugs
acetylcysteinecalcitriol
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT04643821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04643821.